In combination with OV-mediated direct tumor cell killing, CD56 activation and CD56bright NK cells induce a spectrum of activity via antiviral pathways, including NK cell-mediated tumor cell killing and regulation of adaptive NK cells to lymph nodes by transport of IFN-γ-expressing CD56 (132). This evidence concerns the gene NCAM1 and neoplasm.